| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.29 | 4e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.25 | 1e-05 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 7e-05 |